Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

EP BIOCOMPOSITES Share Price   (EPBP)



Here is the latest stock price and chart of EP BIOCOMPOSITES. For more details, see the EP BIOCOMPOSITES company fact sheet and quarterly results.

Revealing Soon: A Potential Huge Investing Opportunity for Investors

REFRESH
Live BSE Quotes May 22, 2024 (Close)
Price (Rs)146.00 Open (Rs) 138.00 High (Rs) 146.00 Low (Rs) 138.00
% Change8.19 Volume 1,500 Value (Rs) 212,000 52-Week H/L 254.00 / 122.00
Live NSE Quotes
Not listed
Change
1 Day
8.19%
Valuation
EPS (Rs)* - P/E Ratio (x) - Market Cap (Rs m) 245.50 P/BV (x) 2.92 Dividend Yield (%) 0.00
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

As of March 2024, company promoters held 70.08% stake in , with no shares having been pledged. To know more, check out the latest shareholding pattern of .

Before you go, here's an alert on you may want to take note of...

Upcoming Corporate Actions for

DateAnnouncementEx-Date
24-May-2024Quarterly Results-
Data Source: Equitymaster, Accord Fintech

List of All Upcoming Corporate Actions



FAQs on EP BIOCOMPOSITES

What is the EP BIOCOMPOSITES share price today?

The last traded price of EP BIOCOMPOSITES was Rs 146.0 on the BSE, up 8.2% over the previous close.

What is the market cap of EP BIOCOMPOSITES?

The current market capitalisation of EP BIOCOMPOSITES stands at Rs 245 m.


Today's Market

Sensex Today Trades Higher | Smallcap Stocks Shine | Gland Pharma Rallies 8% Sensex Today Trades Higher | Smallcap Stocks Shine | Gland Pharma Rallies 8%(10:30 am)

Asian share benchmarks fell on Thursday as markets digested the implications of policymakers in major economies preferring to take patient approach to monetary easing amid sticky inflation.